Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (31-40 of 323) with videos related to

Pageof 33
Sort By:
World Journal of Urology|May 6, 2010
Hot topics in kidney cancer 2010Axel S Merseburger, Börje Ljungberg, Christian Doehn
Der Urologe. Ausg. A|December 6, 2015
[Cardiovascular risk patients under androgen deprivation therapy: Lower risk with GnRH antagonists compared to LHRH agonists?]Axel S Merseburger, Daniel Sedding, Kai Hüter
World Journal of Urology|July 13, 2016
Renal cell carcinomaAxel S Merseburger, Börje Ljungberg, Axel Bex
International Journal of Urology : Official Journal of the Japanese Urological Association|June 17, 2026
Editorial Comment on to Investigate Disparities in Strategies for Low-Risk Prostate Cancer by Facility Type Using the Japan Study Group of Prostate Cancer DatabaseYoichiro Tohi, Axel S Merseburger, Mikio Sugimoto
Clinical Prostate Cancer|March 30, 2004
Molecular markers in prostate cancer: the role in preoperative stagingJudd W Moul, Axel S Merseburger, Shiv Srivastava
Aktuelle Urologie|March 27, 2023
[Prostate Cancer: Side-Effect Management for Androgen Deprivation Therapy]Eva Hellmis, Tobias Niels Mudra, Axel S Merseburger
Aktuelle Urologie|February 5, 2026
[Drug-Drug Interactions as a Challenge in the Monotherapy of Advanced or Metastatic Clear-Cell Renal Cell Carcinoma with VEGFR-Associated Tyrosine Kinase Inhibitors]Hartmut Reinbold, Peter J Goebell, Axel S Merseburger
Mayo Clinic Proceedings|August 3, 2010
Can aquaporin-1 and adipophilin in urine distinguish between malignant and nonmalignant renal lesions?Mario W Kramer, Axel S Merseburger, Hossein Tezval
Current Opinion in Urology|August 2, 2008
Bladder preserving strategies for muscle-invasive bladder cancerAxel S Merseburger, Ira Matuschek, Markus A Kuczyk
Aktuelle Urologie|June 17, 2014
[Prostate carcinoma - does estrogen administration increase the cardiovascular risk?]Christoph A J von Klot, Axel S Merseburger
Pageof 33

Showing results (31-40 of 323) with videos related to

Sort By:
Pageof 33
World Journal of Urology|May 6, 2010
Hot topics in kidney cancer 2010Axel S Merseburger, Börje Ljungberg, Christian Doehn
Der Urologe. Ausg. A|December 6, 2015
[Cardiovascular risk patients under androgen deprivation therapy: Lower risk with GnRH antagonists compared to LHRH agonists?]Axel S Merseburger, Daniel Sedding, Kai Hüter
World Journal of Urology|July 13, 2016
Renal cell carcinomaAxel S Merseburger, Börje Ljungberg, Axel Bex
International Journal of Urology : Official Journal of the Japanese Urological Association|June 17, 2026
Editorial Comment on to Investigate Disparities in Strategies for Low-Risk Prostate Cancer by Facility Type Using the Japan Study Group of Prostate Cancer DatabaseYoichiro Tohi, Axel S Merseburger, Mikio Sugimoto
Clinical Prostate Cancer|March 30, 2004
Molecular markers in prostate cancer: the role in preoperative stagingJudd W Moul, Axel S Merseburger, Shiv Srivastava
Aktuelle Urologie|March 27, 2023
[Prostate Cancer: Side-Effect Management for Androgen Deprivation Therapy]Eva Hellmis, Tobias Niels Mudra, Axel S Merseburger
Aktuelle Urologie|February 5, 2026
[Drug-Drug Interactions as a Challenge in the Monotherapy of Advanced or Metastatic Clear-Cell Renal Cell Carcinoma with VEGFR-Associated Tyrosine Kinase Inhibitors]Hartmut Reinbold, Peter J Goebell, Axel S Merseburger
Mayo Clinic Proceedings|August 3, 2010
Can aquaporin-1 and adipophilin in urine distinguish between malignant and nonmalignant renal lesions?Mario W Kramer, Axel S Merseburger, Hossein Tezval
Current Opinion in Urology|August 2, 2008
Bladder preserving strategies for muscle-invasive bladder cancerAxel S Merseburger, Ira Matuschek, Markus A Kuczyk
Aktuelle Urologie|June 17, 2014
[Prostate carcinoma - does estrogen administration increase the cardiovascular risk?]Christoph A J von Klot, Axel S Merseburger
Pageof 33